By Justice — Elevated Club NYC The cannabis industry is once again watching Washington. On June 29, 2026, the U.S. Drug Enforcement Administration (DEA) will begin a highly anticipated hearing that could help determine whether cannabis should move from Schedule I to Schedule III under federal law. The hearing is scheduled to run through July 15 and is widely viewed as one of the most significant federal cannabis policy events in modern history. (Federal Register) For years, cannabis businesses, patients, advocates, researchers, and investors have pushed for federal reform. While dozens of states have legalized cannabis in some form, federal law has remained largely unchanged. Cannabis has continued to sit alongside drugs classified under Schedule I, creating conflicts between state markets and federal regulations. (Moritz College of Law) In April 2026, the Department of Justice and DEA issued an order moving certain state-licensed medical cannabis products and FDA-approved cannabis medications into Schedule III. However, adult-use cannabis remains federally restricted, leaving much of the industry waiting for broader action. (Reuters) The upcoming hearing is designed to examine whether cannabis as a whole should be transferred to Schedule III. If that happens, the impact could be substantial. (Scarinci Hollenbeck) One of the biggest issues involves taxes. Cannabis businesses currently face IRS Section 280E, which prevents many operators from deducting ordinary business expenses. Moving cannabis to Schedule III could potentially eliminate that burden for qualifying businesses and improve profitability across the industry. (Moritz College of Law) Research could also expand dramatically. Scientists have long argued that Schedule I restrictions create unnecessary barriers to studying cannabis. A Schedule III classification would make research less burdensome and could accelerate medical discoveries involving cannabinoids and therapeutic applications. (Moritz College of Law) Financial institutions are also paying attention. While rescheduling would not automatically solve banking challenges, many industry observers believe it could encourage more traditional financial services to enter the cannabis space. Greater access to banking, lending, and payment processing would be a major step forward for operators nationwide. (Moritz College of Law) At the same time, expectations should remain realistic. Even if cannabis moves to Schedule III, it would not become federally legal overnight. State regulations would still govern local markets, interstate commerce questions would remain unresolved, and federal agencies would continue developing guidance for the industry. (Moritz College of Law) The hearing itself has already generated controversy. Reports indicate that some cannabis reform advocates and organizations were excluded from participating, while opponents of rescheduling received invitations to testify. Critics argue that a hearing of this magnitude should include a broader range of perspectives from patients, businesses, and industry stakeholders. (Marijuana Moment) Regardless of the outcome, June 29 represents a pivotal moment. The federal government is actively reconsidering cannabis policy in a way that would have seemed impossible a decade ago. Whether the result is full Schedule III status, partial reform, or additional delays, the decisions made during this process will influence the future of cannabis businesses, consumers, and medical research for years to come. For operators, brands, and consumers across New York and beyond, this is the cannabis story to watch in 2026. As the hearing begins, one thing is clear: the conversation around federal cannabis reform is no longer about if change is coming. It’s about how far that change will go.

New York City moves fast. Between long workdays, packed schedules, late-night adventures, and everything in between, finding time to visit a dispensary isn’t always convenient. That’s where Elevated Club NYC comes in. Elevated Club NYC was created with a simple goal: provide premium cannabis products through a delivery experience that is fast, reliable, discreet, and customer-focused. We understand that modern consumers value convenience just as much as quality. That’s why we’ve built our service around bringing top-tier cannabis directly to your door. Unlike traditional retail experiences, Elevated Club NYC operates as a delivery-focused service designed for people who want access to premium products without the hassle of storefront lines, crowded waiting rooms, or long travel times. Whether you’re relaxing at home, finishing a late shift, hosting friends, or simply looking to unwind, our team is ready to help you stay elevated. Curated Products, Not Endless Noise The cannabis market is crowded with options, but not all products are created equal. Our focus is on quality over quantity. Every product is carefully selected based on factors such as freshness, potency, aroma, flavor profile, and overall customer experience. Our menu regularly features: • Premium Flower • Pre-Rolls • Concentrates • Edibles • Vapes • Accessories • Limited Releases We prioritize products that meet our standards for consistency and customer satisfaction. The result is a menu designed to help consumers shop confidently without feeling overwhelmed. Fast and Discreet Delivery One of the most important aspects of our business is discretion. Many customers appreciate privacy and professionalism when ordering cannabis. Every delivery is handled with care to ensure a smooth and comfortable experience. Our delivery process is designed to be: • Fast • Simple • Secure • Professional • Reliable No storefront. No waiting room. No unnecessary complications. Just premium cannabis delivered directly to you. Serving Brooklyn and Beyond Elevated Club NYC proudly serves customers throughout key Brooklyn neighborhoods including Williamsburg, Bed-Stuy, Bushwick, and Greenpoint. Our goal is to provide dependable access to premium cannabis while maintaining exceptional customer service and communication. As demand continues to grow, we remain committed to improving the delivery experience through faster response times, curated products, and customer-focused service. More Than Cannabis Cannabis is about more than products. It’s about relaxation, creativity, wellness, connection, and personal enjoyment. Everyone’s experience is different, which is why we believe customers deserve access to a wide variety of products that fit their individual lifestyle. Whether you’re looking for something uplifting, relaxing, social, creative, or simply enjoyable after a long day, Elevated Club NYC aims to provide options that match your preferences. The Elevated Club NYC Difference What separates Elevated Club NYC from other delivery services is our commitment to consistency. We focus on delivering a dependable experience every time you place an order. Quality products. Professional service. Fast delivery. Discreet experience. That’s the standard we hold ourselves to every day. When you’re looking for premium cannabis delivered directly to your door, Elevated Club NYC is here to help. Top Shelf. Fire Flower. Elevated Experiences. Stay Elevated.

Medical marijuana remains one of the most discussed topics in modern healthcare. While cannabis has become increasingly accepted across the United States, many people still have questions about what it can actually do, who it may help, and what risks should be considered before use. Research suggests that medical cannabis may offer relief for a variety of conditions. Patients suffering from chronic pain often report reduced discomfort and improved quality of life. Medical marijuana has also been used to help manage nausea and vomiting associated with chemotherapy, improve appetite in patients dealing with HIV/AIDS, and reduce seizure frequency in certain forms of epilepsy. For some individuals with multiple sclerosis, cannabis may help reduce muscle spasms and improve comfort. At the same time, medical marijuana is not without potential drawbacks. Some studies have linked long-term or heavy use to memory issues, reduced concentration, and impaired decision-making. Smoking cannabis may irritate the lungs and respiratory system. Certain users may experience anxiety, paranoia, or dependency, particularly when products are used frequently or in high doses. As research continues, scientists are working to better understand the long-term effects of cannabis on brain development, cardiovascular health, and overall wellness. The reality is that cannabis is neither a miracle cure nor a dangerous substance for everyone. Like many medical treatments, its benefits and risks depend on factors such as dosage, product type, individual health conditions, and responsible use. As legalization expands and research grows, consumers have access to more information than ever before. Understanding both sides of the conversation allows people to make informed decisions based on science rather than stigma. At Elevated Club NYC, we believe education is elevation. Whether you’re exploring cannabis for wellness, recreation, or simply curiosity, staying informed is one of the best ways to make smarter choices. Knowledge beats hype. Facts beat opinions. The higher perspective comes from understanding the full picture.

By Justice — Elevated Club NYC For years, opponents of cannabis legalization have repeated a familiar warning: legal cannabis would inevitably lead to more teenagers using marijuana. It has been one of the most common arguments used in debates surrounding cannabis policy across the United States. Critics have often claimed that legal markets normalize marijuana use, increase accessibility, and encourage experimentation among young people. However, new data out of Colorado continues to challenge that narrative. According to findings highlighted by Marijuana Moment and supported by state research, teen marijuana use in Colorado remains lower today than it was before adult-use cannabis legalization. The results add to a growing body of evidence suggesting that regulated cannabis markets may not produce the surge in youth consumption that many opponents predicted. The findings are particularly significant because Colorado was one of the first states to legalize adult-use cannabis, making it one of the most closely watched cannabis markets in the country. More than a decade after legalization, policymakers, researchers, public health officials, and industry observers continue to examine the long-term effects of regulation. The latest numbers tell an interesting story. A Decade Of Data When Colorado voters approved adult-use cannabis legalization in 2012, critics warned of serious consequences for youth consumption. Many feared that legal stores, increased visibility, and changing public attitudes would make cannabis more attractive to teenagers. Those concerns were not limited to Colorado. Similar arguments appeared in virtually every legalization campaign across the country. Yet year after year, the data has painted a different picture. Colorado’s youth surveys show marijuana use among high school students has generally trended downward since legalization. Current rates are lower than those reported before the launch of the state’s regulated adult-use market. The newest findings continue that trend and further weaken the argument that legalization automatically leads to increased youth consumption. While cannabis remains one of the most commonly used substances among teenagers, researchers note that the relationship between legalization and youth use is far more complex than many early critics suggested. Why The Results Matter The significance of these findings extends far beyond Colorado. Today, nearly half of the United States lives in a state where adult-use cannabis is legal. Policymakers in additional states continue debating legalization measures, while federal lawmakers discuss broader cannabis reform. As those conversations continue, one question repeatedly emerges: “What happens to youth marijuana use after legalization?” Colorado provides one of the longest-running real-world case studies available. More than ten years of data now exists for researchers to evaluate. Instead of relying on speculation, lawmakers can examine actual outcomes. The continued decline in teen cannabis use suggests that legalization alone does not determine youth behavior. Other factors appear to play important roles, including education, parental involvement, prevention programs, enforcement mechanisms, and regulated retail systems. The Difference Between Regulation And Prohibition One reason many experts point to Colorado’s experience is the distinction between regulated markets and illegal markets. Under prohibition, cannabis sales occur without age verification requirements, testing standards, product labeling, or government oversight. Illegal dealers generally do not check identification. Licensed cannabis retailers do. In Colorado and other legal states, businesses face substantial penalties for selling cannabis products to underage consumers. Compliance checks, licensing requirements, surveillance systems, and strict regulations create multiple layers of accountability. This structure creates barriers that simply do not exist in unregulated markets. Supporters of legalization have long argued that regulation provides better protections than prohibition because it allows governments to control access while generating funding for education and enforcement programs. Colorado’s data gives policymakers additional information to evaluate those claims. Education Plays A Major Role Cannabis legalization has often been accompanied by expanded public education efforts. Many states dedicate portions of cannabis tax revenue to youth prevention initiatives, school programs, public awareness campaigns, and substance abuse education. These programs are designed to provide accurate information rather than relying solely on fear-based messaging. Research has repeatedly shown that education tends to be more effective when it is credible, evidence-based, and focused on informed decision-making. Today’s teenagers have access to more information than previous generations. They are increasingly exposed to discussions about health, science, and risk factors through schools, media, and digital platforms. The combination of education and regulation may be helping contribute to the continued decline observed in Colorado. What Researchers Are Watching While the data is encouraging for supporters of legalization, researchers continue monitoring several important factors. Youth cannabis use is only one measure. Scientists also study: • Frequency of use • Product potency • Perceptions of risk • Mental health outcomes • Academic performance • Substance use trends • Public health indicators Understanding the full impact of legalization requires examining multiple variables over long periods of time. Most researchers agree that cannabis policy should continue evolving based on evidence rather than assumptions. Colorado’s experience provides valuable information, but ongoing research remains essential. The Importance Of Evidence-Based Policy One lesson emerging from the legalization debate is the importance of allowing data to guide public policy. Predictions are useful. Evidence is better. Over the past decade, many concerns about legalization have been tested against real-world outcomes. Some concerns have proven valid and required policy adjustments. Others have not materialized as expected. The question of youth cannabis use is one of the most frequently cited examples. Rather than experiencing dramatic increases, Colorado has seen rates generally move in the opposite direction. That does not mean cannabis is risk-free or appropriate for minors. In fact, virtually every public health organization agrees that adolescents should avoid cannabis use because the brain continues developing into early adulthood. However, the data suggests that legalization and increased youth consumption are not automatically linked. That distinction matters when lawmakers evaluate future policy decisions. Looking Beyond Headlines Cannabis policy debates often become polarized. Supporters and opponents alike can sometimes focus on narratives that reinforce existing beliefs. The value of studies like Colorado’s lies in their ability to move the conversation beyond assumptions and toward measurable outcomes. Public policy works best when it responds to evidence. As more states collect long-term data, researchers are gaining a clearer understanding of what legalization actually looks like in practice. The findings do not suggest that legalization solves every problem. Nor do they suggest that concerns about youth access should disappear. Instead, they indicate that carefully regulated cannabis markets may be capable of maintaining strong protections for minors while providing legal access for adults. What This Means For The Future Colorado’s experience will continue influencing cannabis policy discussions nationwide. As additional states consider legalization and federal reform efforts continue, lawmakers will increasingly look toward established markets for guidance. The latest findings add another piece of evidence to the growing conversation. Teen marijuana use in Colorado remains lower than it was before legalization. That reality challenges one of the most persistent arguments against regulated cannabis markets. For advocates of evidence-based policy, the message is straightforward: Data matters. Research matters. Facts matter. And when it comes to understanding the real-world effects of cannabis legalization, long-term evidence continues to provide a clearer picture than speculation ever could. As the cannabis industry matures and more research becomes available, one thing becomes increasingly clear: successful cannabis policy is built on regulation, education, accountability, and evidence—not fear. Education is elevation.

By Justice — Elevated Club NYC As cannabis research expands worldwide, scientists continue uncovering new ways cannabinoids interact with the human body. A recent study highlighted by ScienceDaily adds to a growing body of evidence suggesting certain cannabis-derived compounds may help regulate inflammation, one of the key biological processes involved in many chronic diseases. Inflammation serves an important purpose. It is the body’s natural defense mechanism against injury, infection, and harmful stimuli. However, when inflammation becomes chronic, it can contribute to a range of health issues, including cardiovascular disease, autoimmune disorders, arthritis, and neurodegenerative conditions. Researchers have long been interested in the endocannabinoid system, a network of receptors and signaling molecules that helps regulate mood, appetite, sleep, pain perception, and immune function. Cannabinoids from cannabis plants interact with this system, influencing numerous physiological processes. The new research examined how specific cannabinoids affect inflammatory pathways. Scientists observed that certain cannabis-derived compounds appeared to influence immune responses and reduce markers associated with excessive inflammation. While the findings are promising, researchers caution that the work remains in the early stages. Much of the data comes from laboratory and preclinical models rather than large-scale human clinical trials. As a result, scientists are careful not to overstate the immediate implications for patient care. Still, the study contributes to a growing scientific conversation surrounding cannabis and its therapeutic potential. Cannabinoids such as CBD have already gained significant attention for their anti-inflammatory properties. Unlike THC, CBD does not produce intoxicating effects, making it particularly attractive to researchers exploring medical applications. THC itself may also possess anti-inflammatory properties, although its psychoactive effects often require additional consideration when developing therapies. The latest findings suggest researchers may be able to identify specific cannabinoid pathways that could eventually be targeted by future medications. Rather than relying solely on whole-plant cannabis products, scientists are increasingly investigating isolated compounds and synthetic cannabinoid formulations that can deliver more predictable outcomes. This approach mirrors developments seen in other areas of pharmaceutical research, where naturally occurring compounds serve as the foundation for highly specialized medicines. For the cannabis industry, studies like this are important because they continue expanding scientific understanding beyond recreational use. As research advances, cannabinoids are increasingly being evaluated for their potential role in addressing complex health challenges. However, it is essential to maintain realistic expectations. Scientific progress occurs through repeated testing, peer review, and clinical validation. What appears promising in a laboratory setting may require years of additional research before becoming a standard treatment option. The growing acceptance of cannabis research has allowed scientists to ask more sophisticated questions about how cannabinoids interact with human biology. Every new study contributes another piece to that puzzle. As regulations evolve and research barriers continue to fall, the scientific community will gain a clearer understanding of where cannabis-derived compounds fit within modern medicine. For now, the latest findings provide another example of why cannabis remains one of the most actively researched botanical compounds in the world. The future of cannabinoid science continues to evolve, and researchers are only beginning to uncover the full range of possibilities hidden within the plant.

By Justice — Elevated Club NYC New York’s cannabis industry has entered a new chapter. Following a recent appellate court decision, the injunction that had limited cannabis enforcement actions across the state has been lifted. As a result, the New York State Office of Cannabis Management (OCM) and local law enforcement agencies once again have broader authority to inspect, seize products, and take enforcement action against businesses operating outside of state regulations. For consumers, the change may not seem significant at first glance. However, the decision has the potential to reshape the cannabis marketplace across New York City and beyond. The original injunction stemmed from legal challenges surrounding enforcement practices used against certain hemp and cannabis retailers. During the period the injunction was in effect, regulators faced restrictions on how they could conduct inspections and raids. With those limitations removed, enforcement efforts are expected to increase throughout the state. The primary target of these actions will be unlicensed cannabis stores and businesses selling products outside of New York’s legal framework. State officials have repeatedly stated that protecting the regulated market remains a priority. That means increased scrutiny of unauthorized retailers, illegal cannabis products, and businesses operating without the proper licenses. For licensed operators, the ruling is generally viewed as a positive development. Since New York launched adult-use cannabis sales, legal businesses have faced competition from thousands of unlicensed shops. Many licensed operators have argued that illegal retailers create an uneven playing field by avoiding the costs, taxes, testing requirements, and regulations that licensed businesses must follow. Consumers may begin to notice fewer illicit storefronts and increased enforcement activity throughout New York City. The state’s goal is to encourage purchases through licensed businesses where products undergo laboratory testing, labeling requirements, and regulatory oversight. At Elevated Club NYC, we continue to support a regulated cannabis market that prioritizes product quality, consumer safety, and transparency. As New York’s cannabis industry evolves, staying informed about regulatory changes helps consumers make educated decisions about where they choose to shop. The legal cannabis market in New York is still developing, and decisions like this will continue to shape its future. Whether you’re a consumer, entrepreneur, or industry observer, one thing is clear: regulators are signaling that enforcement remains a major focus moving forward. As always, stay informed, stay compliant, and stay elevated.

In a city where convenience matters, Elevated Club NYC has built a reputation for delivering a cannabis experience that is fast, discreet, and customer-focused. Serving neighborhoods throughout Brooklyn and beyond, the delivery-only service has become a preferred option for customers who value reliability, quality products, and a smooth ordering process. One of the most common themes found in customer feedback is convenience. Unlike traditional retail experiences that require traveling to a storefront, waiting in line, and navigating crowded locations, Elevated Club NYC brings products directly to customers’ doors. Many customers highlight the ease of ordering and the ability to receive products without disrupting their day. Speed is another factor that consistently earns praise. Reviews frequently mention quick turnaround times and dependable service, especially during evenings and late-night hours when many consumers are looking for a convenient option. For customers balancing work, family, and busy schedules, fast delivery has become a defining feature of the Elevated Club NYC experience. Discretion also plays a major role in customer satisfaction. Many customers appreciate the professional approach taken by the service. Orders are delivered directly and privately, creating a comfortable experience for consumers who prefer a low-profile transaction. This commitment to discretion has helped Elevated Club NYC establish trust with a growing customer base throughout New York City. Product quality is another area where customers regularly express positive feedback. Reviews often reference flavorful flower, carefully selected strains, and a menu that offers a variety of options for different preferences. Whether customers are looking for classic favorites or newer selections, many report consistent quality and a dependable experience. Customer service is frequently highlighted as a strength. Friendly communication, order updates, and responsive support contribute to an experience that feels personal rather than transactional. Customers often note that questions are answered quickly and that the ordering process remains simple from start to finish. What separates Elevated Club NYC from many competitors is its focus on the overall customer experience. The company operates with a straightforward philosophy: make ordering easy, make delivery reliable, and make quality the standard. Rather than emphasizing unnecessary complexity, the service focuses on consistency and convenience. As cannabis delivery continues to grow across New York, Elevated Club NYC has positioned itself as a service built around modern consumer expectations. Fast delivery, discreet service, quality products, and attentive customer support have combined to create a positive reputation among customers throughout Brooklyn and surrounding neighborhoods. For many customers, Elevated Club NYC represents more than just delivery—it represents a dependable service designed to fit seamlessly into city life.

New York’s legal cannabis industry continues to evolve, and one of the most exciting developments is the approval of Cannabis Showcase Events, effectively bringing cannabis farmers markets and pop-up cannabis events back to communities across the state. The program allows licensed dispensaries to partner directly with licensed cultivators and processors, creating opportunities for consumers to meet the people responsible for growing and producing their cannabis. (Marijuana Moment) For years, many small cannabis farmers struggled to compete in a market dominated by larger operators and an ongoing illicit market. Cannabis Showcase Events provide a new pathway for cultivators to introduce their products directly to consumers while building brand awareness and strengthening local relationships. These events can take place at farmers markets, public markets, and approved pop-up locations throughout New York. (JD Supra) The new regulations require participating dispensaries to partner with licensed cultivators and processors, ensuring that consumers gain access to authentic, regulated New York-grown cannabis products. The events maintain strict age verification requirements, safety standards, and local oversight while offering a unique shopping experience that resembles traditional agricultural markets. (Marijuana Moment) For consumers, this means greater transparency. Instead of simply purchasing a product from a shelf, shoppers can learn about cultivation methods, terpene profiles, genetics, processing techniques, and the stories behind the brands they support. Similar to visiting a winery or local farm stand, cannabis consumers can develop a deeper connection with the products they choose. (Marijuana Moment) The timing couldn’t be better. New York’s legal cannabis market has experienced tremendous growth, generating billions in sales and expanding to hundreds of licensed dispensaries across the state. Regulators continue to focus on building a stable and sustainable industry that supports small businesses, farmers, processors, retailers, and consumers alike. (New York Post) Cannabis Showcase Events also represent another step toward reducing reliance on the illicit market. By giving licensed operators more opportunities to reach consumers, New York is helping legal businesses compete while ensuring products are tested, tracked, and sold through regulated channels. This benefits consumers through improved safety, product consistency, and accountability. (Office of Cannabis Management) For New York cannabis cultivators, the return of cannabis farmers markets is more than a regulatory change—it is a chance to showcase craftsmanship, educate consumers, and build stronger local cannabis communities. As these events begin appearing across the state, they are expected to become an important part of New York’s growing cannabis culture. At Elevated Club NYC, we believe consumers deserve access to quality cannabis and accurate information. The approval of Cannabis Showcase Events is another sign that New York’s legal cannabis industry is maturing and creating new opportunities for growers, retailers, and customers alike. The future of cannabis in New York is local, transparent, and community-driven—and Cannabis Showcase Events are helping lead the way.

As cannabis becomes more widely accepted and legalized across the United States, an important public health question continues to emerge: What happens when cannabis is smoked indoors around children? While research on cannabis smoke is still developing, recent studies have found that children living in homes where cannabis is smoked indoors can be exposed to THC and other smoke-related pollutants through secondhand and thirdhand smoke exposure. (PubMed⁠) A 2025 study published in JAMA Network Open found that children living in homes where cannabis was smoked indoors had significantly higher odds of testing positive for cannabis exposure through urinary biomarkers. Researchers concluded that smoking cannabis inside the home substantially increases a child’s exposure to cannabis smoke and its chemical byproducts. (JAMA Network⁠) Cannabis smoke contains many of the same toxic compounds found in tobacco smoke, including fine particulate matter, respiratory irritants, volatile organic compounds, and carcinogenic chemicals. Although cannabis and tobacco are different substances, the combustion process creates similar indoor air pollutants. (CDC⁠) Researchers from the National Institutes of Health and other institutions have reported that indoor cannabis smoking dramatically increases airborne particle concentrations, exposing children to pollutants that can remain suspended in indoor air and settle onto surfaces throughout the home. (PMC⁠) This exposure does not necessarily require a child to be in the same room. Studies have detected cannabis metabolites in children living in homes where adults smoked cannabis elsewhere in the residence. Smoke particles and THC-containing residue can travel through ventilation systems, doorways, and common living spaces. (Mount Sinai Health System⁠) Emerging research has also linked secondhand cannabis smoke exposure with increased respiratory illnesses in children. One study found an association between cannabis smoke exposure and more frequent viral respiratory infections among pediatric patients. Other studies suggest children exposed to secondhand cannabis smoke may experience higher rates of asthma-related symptoms and respiratory irritation. (PubMed⁠) The Centers for Disease Control and Prevention (CDC) warns that THC can be transferred to children through secondhand cannabis smoke. In some cases, exposure levels have been high enough to produce detectable THC metabolites in children’s bodies. While the long-term developmental effects are still being investigated, health experts generally agree that reducing children’s exposure is a prudent precaution. (CDC⁠) The current scientific consensus is straightforward: children should not be exposed to cannabis smoke indoors. As research continues, evidence increasingly shows that indoor cannabis smoking can affect air quality, expose children to THC, and potentially contribute to respiratory health concerns. (PubMed⁠) For adults who choose to consume cannabis, public health experts recommend avoiding smoking or vaping inside homes and vehicles when children are present. Taking simple steps to reduce indoor exposure can help create a healthier environment for everyone in the household. (CDC⁠) This version is educational, evidence-based, and appropriate for publication on a cannabis industry website without making unsupported claims.

The battle over hemp-derived cannabis products in Texas has entered another dramatic chapter. In a decision that could have major consequences for consumers, retailers, manufacturers, and lawmakers across the country, the Texas Fifteenth Court of Appeals has allowed the state’s controversial hemp regulations to move forward while a larger legal battle continues. The ruling effectively reinstates restrictions on many popular hemp-derived products, including THCA flower and concentrates that have become a cornerstone of the modern hemp market. For months, Texas businesses had been operating under a temporary injunction that blocked enforcement of new regulations from the Texas Department of State Health Services (DSHS). That injunction had allowed many hemp retailers to continue selling products that consumers have increasingly embraced as alternatives to traditional cannabis products. Now, the regulatory landscape has shifted once again. The Court Decision The appeals court denied an emergency request from hemp industry groups seeking to keep the injunction in place. As a result, Texas regulators may once again enforce the state’s “Total THC Rule,” a regulation that dramatically changes how hemp products are evaluated under Texas law. The ruling follows months of legal back-and-forth between state regulators and hemp industry advocates. Courts had repeatedly paused and reinstated portions of the rules, creating significant uncertainty for businesses attempting to comply with changing requirements. Industry leaders describe the situation as one of the most unstable regulatory periods the Texas hemp market has experienced since hemp legalization. Understanding THCA At the center of the dispute is THCA, a naturally occurring cannabinoid found in cannabis plants. Unlike Delta-9 THC, THCA itself is not intoxicating. However, when heated through smoking, vaping, or cooking, THCA converts into Delta-9 THC—the compound most commonly associated with the psychoactive effects of cannabis. For years, hemp businesses have relied on the distinction between THCA and Delta-9 THC to sell flower and concentrates that technically comply with hemp laws while still providing effects similar to traditional cannabis once consumed. The Texas Department of State Health Services argues that this distinction creates a loophole that undermines the intent of hemp regulations. The Total THC Rule Explained The reinstated rule requires regulators to count THCA as part of a product’s total THC content. Specifically, Texas regulators now calculate THCA at 88% of its potential Delta-9 THC conversion value when determining whether a hemp product exceeds legal limits. This seemingly technical change has enormous practical implications. Many hemp flower products that previously qualified as legal under Texas law could now exceed regulatory thresholds once THCA is included in testing calculations. Products that retailers have sold legally for years may no longer qualify for sale under the revised framework. For consumers, that means fewer products on store shelves and reduced access to hemp-derived alternatives. For businesses, it could mean reformulating products, changing inventory strategies, or removing entire product categories from their offerings. Financial Impact on Businesses The regulatory changes extend beyond product testing. One of the most controversial aspects of the Texas rules involves licensing fees for hemp operators. According to court filings and reporting, annual registration fees for retailers would jump from $150 to $5,000 per location. Manufacturing fees would increase from $250 annually to $10,000. These increases represent some of the most dramatic fee hikes seen in the hemp industry. Supporters argue that higher fees help fund oversight and consumer protection efforts. Critics contend that the increases disproportionately affect small businesses and independent operators that lack the resources of larger cannabis companies. Industry advocates warn that many small retailers may struggle to absorb the added costs while simultaneously navigating stricter product regulations. Why This Matters Beyond Texas Texas is one of the largest hemp markets in the United States. What happens there often influences conversations in other states. The legal questions surrounding THCA, total THC calculations, and hemp-derived cannabinoids have become increasingly important as states attempt to balance consumer demand with regulatory oversight. Across the country, lawmakers continue to debate how hemp products should be classified and regulated. Some states have moved toward tighter restrictions. Others have embraced broader hemp markets. Texas now finds itself at the center of that national conversation. The outcome of the ongoing litigation could serve as a roadmap for future regulatory actions elsewhere. The Industry Response Hemp industry groups argue that the new rules threaten a market that supports thousands of jobs and serves consumers seeking legal cannabinoid products. Business owners have repeatedly warned that broad restrictions on THCA products could remove a significant portion of the existing hemp marketplace. Previous estimates suggested that smokable hemp products account for well over half of the Texas hemp market. Retailers also point to consumer demand. Many customers choose hemp-derived products because they offer legal access to cannabinoids in states where adult-use cannabis remains prohibited. Industry advocates maintain that consumers should continue to have access to compliant hemp products while lawmakers develop clearer regulatory frameworks. Consumer Considerations For Texas consumers, the current environment remains complicated. Possession laws and product availability continue to evolve as litigation proceeds. Legal experts recommend that consumers stay informed about changing regulations and purchase products from reputable businesses that provide transparent testing and compliance documentation. Because enforcement policies may vary, consumers should pay close attention to packaging, labeling, and product certifications when purchasing hemp-derived products. The legal distinction between hemp and marijuana remains one of the most confusing aspects of cannabis policy nationwide. What Happens Next? The legal battle is far from over. The underlying lawsuit challenging Texas hemp regulations continues through the court system, and additional hearings are expected in the coming months. A trial on the merits has been scheduled as the broader dispute moves forward. Future rulings could once again alter enforcement, product availability, or licensing requirements. Until then, businesses, consumers, and policymakers will continue navigating a rapidly evolving regulatory landscape. The Bigger Picture The Texas hemp case highlights a challenge facing regulators nationwide. Cannabis laws were written during a period when many of today’s hemp-derived products did not exist. Advances in cultivation, extraction, and cannabinoid science have outpaced many regulatory frameworks. As a result, courts and lawmakers are increasingly being asked to define where hemp ends and cannabis begins. The answer will shape the future of the industry. For now, Texas has taken a significant step toward tighter oversight of hemp-derived THC products. Whether that approach ultimately survives legal scrutiny remains to be seen. One thing is certain: the outcome will be watched closely by cannabis businesses and consumers across the United States.

As cannabis legalization expands across the United States, more travelers are asking the same question: Can you legally fly with marijuana? A recent Fox News report highlights growing confusion surrounding TSA guidance, federal cannabis policy, and new public health warnings related to marijuana use. The discussion comes as millions of Americans live in states where cannabis is legal, while federal law continues to classify marijuana differently than many state governments. The Transportation Security Administration maintains that its primary mission is transportation security—not actively searching for cannabis. However, if marijuana is discovered during screening, TSA officers may refer the situation to local law enforcement depending on airport policies and local regulations. That distinction creates significant confusion for travelers. Many consumers assume that because cannabis is legal in their home state, carrying marijuana through airport security is automatically permitted. In reality, airports operate within a federal transportation system where cannabis remains subject to federal restrictions. The Fox News report also highlights concerns from health experts regarding increasingly potent cannabis products now available in legal markets. Today’s marijuana products often contain THC concentrations dramatically higher than what consumers encountered decades ago. Modern concentrates, vape cartridges, infused products, and high-potency flower can produce significantly stronger effects than many people anticipate. Health experts cited in the report warn that inexperienced consumers may underestimate potency, leading to unwanted reactions including anxiety, paranoia, dizziness, panic attacks, impaired judgment, and accidental overconsumption. These concerns become particularly important when travel is involved. Airports, crowded terminals, security checkpoints, delayed flights, unfamiliar environments, and long travel days can already create stress. Combining those situations with unfamiliar cannabis products may increase the likelihood of uncomfortable experiences for some users. At the same time, advocates emphasize that regulated cannabis markets provide product testing, labeling, dosage information, and consumer education tools that were largely unavailable during prohibition. The issue ultimately reflects a broader challenge facing modern cannabis policy. Public acceptance has moved faster than federal regulations. Millions of Americans legally purchase cannabis in licensed markets, yet federal transportation rules, interstate commerce restrictions, workplace policies, and banking regulations remain fragmented. For travelers, that means understanding local laws may not be enough. Departure airports, destination states, airline policies, federal transportation regulations, and product types can all affect what is legally permitted. Health professionals also continue recommending responsible consumption practices, particularly for new users. Understanding THC potency, starting with lower doses, avoiding overconsumption, and remaining aware of individual tolerance levels remain among the most common recommendations. The cannabis industry itself is increasingly focusing on education rather than simply access. As legalization matures, conversations are expanding beyond whether cannabis should be legal and toward questions involving public health, responsible use, consumer safety, and regulatory consistency. The TSA discussion illustrates that evolution perfectly. Cannabis may be more accessible than ever, but understanding how laws, health considerations, and transportation systems interact remains essential for consumers navigating today’s legal landscape. At Elevated Club NYC, we believe cannabis education is just as important as cannabis access. Because informed consumers make better decisions—whether they’re at home or 30,000 feet in the air.

As cannabis legalization expands and public acceptance continues growing, researchers are asking increasingly complex questions about how marijuana affects long-term health. One area receiving significant scientific attention is reproductive health. According to research highlighted by News-Medical, scientists are investigating whether cannabis use may alter sperm DNA through a process known as epigenetic modification. While researchers continue studying the topic, early findings suggest cannabis exposure could potentially influence gene expression patterns within sperm cells. Importantly, this does not mean cannabis changes a person’s DNA sequence itself. Instead, researchers are examining epigenetics—the biological mechanisms that help determine how genes are activated, suppressed, or expressed. Epigenetic changes can influence cellular behavior without altering the underlying genetic code. The concept has become one of the fastest-growing fields in modern biology. Scientists increasingly understand that environmental factors such as nutrition, stress, sleep patterns, pollutants, alcohol consumption, tobacco use, and drug exposure may influence epigenetic markers throughout the body. Cannabis is now part of that conversation. Researchers studying sperm samples have identified differences in DNA methylation patterns among some cannabis users compared to non-users. DNA methylation is one of the primary epigenetic mechanisms responsible for regulating gene activity. The findings have generated interest because sperm cells play a direct role in reproduction and fetal development. However, scientists emphasize that much remains unknown. Most researchers agree that current evidence does not prove cannabis causes infertility, birth defects, or specific health outcomes through epigenetic changes alone. Many studies remain small, observational, and limited by factors such as lifestyle differences, dosage variability, and self-reported cannabis use. That uncertainty is important. Media headlines often oversimplify emerging research findings, creating the impression that scientific conclusions are stronger than they actually are. In reality, researchers continue investigating whether observed epigenetic differences have meaningful long-term biological consequences. Still, the research raises legitimate questions. As cannabis products become stronger and more widely available, understanding their potential impact on reproductive health becomes increasingly relevant—particularly for individuals actively planning families. Healthcare professionals generally recommend discussing cannabis use openly with medical providers when considering fertility, pregnancy, or reproductive planning. Cannabis is not unique in this regard. Alcohol, tobacco, obesity, poor nutrition, environmental toxins, chronic stress, and certain medications are also known to influence reproductive health and sperm quality. The broader lesson is that reproductive biology is highly sensitive to lifestyle factors. For the cannabis industry, studies like these highlight the growing importance of evidence-based education. As legalization expands, consumers increasingly expect accurate information not only about benefits, but also about potential risks and unanswered scientific questions. That transparency ultimately strengthens trust. The future of cannabis research will likely focus less on whether cannabis affects the body—which scientists already know it does—and more on precisely how those effects occur across different populations, dosage levels, and life stages. At Elevated Club NYC, we believe informed consumers make better decisions. Cannabis research continues evolving rapidly, and understanding both the opportunities and uncertainties remains essential as science catches up with legalization. Because the most important cannabis conversations are often the ones still being studied.